Richard S Levy
Director · 9 filings · Latest: Aug 1, 2026
Kiniksa Pharmaceuticals International, plc
Kodiak Sciences Inc.
MADRIGAL PHARMACEUTICALS, INC.
Protara Therapeutics, Inc.
| Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Filing |
|---|---|---|---|---|---|---|---|---|---|
KNSA | Richard S Levy | Director | Aug 1, 2026 | Option Exercise | — | 403 | — | 22,359 | |
KNSA | Richard S Levy | Director | May 29, 2026 | Option Exercise | — | 2,799 | — | 21,956 | |
MDGL | Richard S Levy | Director | May 22, 2026 | Sale | $515.44 | 5,682 | $2.9M | 22,015 | |
MDGL | RICHARD LEVY | — | May 22, 2026 | Proposed Sale | $513.59 | 5,682 | $2.9M | — | |
MDGL | Richard S Levy | Director | Feb 23, 2026 | Option Exercise | $7.36 | 2,500 | $18.4K | 27,697 | |
KNSA | Richard S Levy | Director | Feb 1, 2026 | Option Exercise | — | 683 | — | 19,157 | |
MDGL | Richard S Levy | Director | Jan 26, 2026 | Option Exercise | $16.46 | 4,000 | $65.8K | 25,197 | |
MDGL | RICHARD S LEVY | — | Nov 13, 2025 | Proposed Sale | $528.94 | 8,500 | $4.5M | — | |
MDGL | RICHARD S LEVY | — | Nov 7, 2024 | Proposed Sale | $338.22 | 5,000 | $1.7M | — | |
MDGL | RICHARD S LEVY | — | Nov 1, 2024 | Proposed Sale | $259.34 | 5,000 | $1.3M | — |